Coumarin-Based Azo Derivatives With Trifluoromethyl Substituents: A Combined Experimental and Computational Approach Toward Novel Anticancer Agents
| dc.contributor.author | Dilek, Omer | |
| dc.contributor.author | Yesil, Tolga Acar | |
| dc.contributor.author | Tilki, Tahir | |
| dc.date.accessioned | 2026-04-25T14:19:44Z | |
| dc.date.available | 2026-04-25T14:19:44Z | |
| dc.date.issued | 2026 | |
| dc.department | Sinop Üniversitesi | |
| dc.description.abstract | Cancer's global prevalence demands novel therapeutic agents with improved efficacy and selectivity. In this study, six azo-containing derivatives featuring trifluoromethyl (& horbar;CF3) groups and a coumarin scaffold were comprehensively examined, five of which were newly synthesized. Their chemical structures were confirmed using FTIR, UV-Vis, and NMR (1H and 13C) spectroscopy. DFT calculations (B3LYP/6-311++G(d,p)) supported the experimental data, showing strong agreement between theoretical and observed spectra. All compounds fulfilled Lipinski's rule of five, according to ADMEt studies; however, compounds 4b and 4c showed the lowest projected toxicity (LD50: 6480 mg/kg). High binding affinities toward cancer-related VEGFR2 protein targets (PDB IDs: 3VO3, 6GQO, 3VHE, and 3WZD) were found via molecular docking. The compound that interacted with 3VHE the most was compound 5a (-11.2 kcal/mol). The 6GQO-4a complex was shown to be the most stable (-120.099 kJ/mol) by MM/PBSA analysis. This finding was confirmed by 100 ns molecular dynamics simulations that showed constant hydrogen bonding and stable RMSD values. These results point to compound 4a as a promising lead molecule for the development of anticancer drugs, which calls for additional in vitro and in vivo research. | |
| dc.identifier.doi | 10.1002/slct.73117 | |
| dc.identifier.issn | 2365-6549 | |
| dc.identifier.issue | 14 | |
| dc.identifier.scopusquality | N/A | |
| dc.identifier.uri | https://doi.org/10.1002/slct.73117 | |
| dc.identifier.uri | https://hdl.handle.net/11486/8144 | |
| dc.identifier.volume | 11 | |
| dc.identifier.wos | WOS:001737239300001 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | en | |
| dc.publisher | Wiley-V C H Verlag Gmbh | |
| dc.relation.ispartof | Chemistryselect | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20260420 | |
| dc.subject | Anticancer | |
| dc.subject | Azo-coumarins | |
| dc.subject | Molecular docking | |
| dc.subject | MD simulation | |
| dc.subject | DFT calculations | |
| dc.title | Coumarin-Based Azo Derivatives With Trifluoromethyl Substituents: A Combined Experimental and Computational Approach Toward Novel Anticancer Agents | |
| dc.type | Article |












